-
Evonik Commissions Catalyst Plant in India
contractpharma
April 15, 2019
Expands production of activated metal catalysts for APIs.
-
WuXi STA Mfg. Facility Passes GMP Inspection
contractpharma
March 28, 2019
New drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European Medical Products Agency
-
Orphanion Enters API Deal with LGM Pharma
contractpharma
March 20, 2019
Expands global access to its niche API services.
-
Global APIs market predicted to reach $245.2 billion by 2024
europeanpharmaceuticalreview
January 08, 2019
Major factors driving the growth of the global APIs market are thought to be the increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals…
-
French inspectors find issues at Indian plant cited earlier by Italy
fiercepharma
January 03, 2019
French inspectors found a lot they didn’t like about an Indian manufacturer when they inspected its operation for consideration of approving its ambroxol hydrochloride API.
-
PCI Synthesis to Become SEQENs
contractpharma
December 20, 2018
PCI Synthesis, a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, is changing its name to SEQENS.
-
Mallinckrodt to spin off its speciality generics business next year
pharmaceutical-technology
December 10, 2018
After two years of planning, UK-based pharmaceutical company Mallinckrodt has announced plans to split its speciality generics and active pharmaceutical ingredients (APIs) business....
-
API: Expensive Drugs to Arrive!
Jinsenshui
August 22, 2018
The State Council of China released the Notice on Issuing the Opinions on Pushing Forward the Pharmaceutical Pricing Reform in 2015 to cancel...
-
WuXi STA plant gets FDA nod for 2 APIs, passing its first inspection
fiercepharma
May 09, 2018
The solid-dose API operation of China’s WuXi had its first visit by FDA inspectors at a new plant in Changzhou, China, and the company says it aced it.